Literature DB >> 1552112

Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure.

S D Katz1, L Biasucci, C Sabba, J A Strom, G Jondeau, M Galvao, S Solomon, S D Nikolic, R Forman, T H LeJemtel.   

Abstract

Impaired endothelial-dependent vasodilation has been demonstrated in two animal models of congestive heart failure and in the coronary circulation of patients with idiopathic dilated cardiomyopathy. To determine whether this impairment contributes to the abnormal peripheral vasomotor tone in patients with congestive heart failure, the local vascular response to intraarterial infusions of graded concentrations (10(-8) M to 10(-5) M) of acetylcholine (an endothelial-dependent vasodilator) and nitroglycerin (a direct-acting vasodilator) was studied in the superficial femoral artery of 19 patients with congestive heart failure (New York Heart Association classes I to IV) and 6 age-matched normal control subjects. The local vascular response was determined from the arterial blood flow velocity pattern obtained by transcutaneous Doppler ultrasonography. Acetylcholine, 10(-5) M, induced a pattern characteristic of vasodilation in all six normal subjects; mean blood flow velocity for the group significantly increased from 11.9 +/- 2.7 to 44.8 +/- 20.9 cm/s (p less than 0.05). In contrast, the same dose of acetylcholine induced a blood flow velocity pattern characteristic of vasodilation in only 4 of the 19 patients with congestive heart failure. Group mean blood flow velocity did not change significantly. Nitroglycerin, 10(-7) M, induced vasodilation in all 6 normal subjects but in only 1 of 19 patients. Nitroglycerin, 10(-5) M, was administered to 10 patients; all 10 demonstrated a pattern characteristic of vasodilation. Thus, acetylcholine-mediated endothelial-dependent vasodilation appears to be impaired in the peripheral vasculature of patients with congestive heart failure. Both endothelial dysfunction and abnormal vascular smooth muscle responsiveness may contribute to abnormal peripheral vasomotor tone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1552112     DOI: 10.1016/0735-1097(92)90271-n

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  58 in total

1.  Assessment of endothelium-mediated vasodilation of the peripheral circulation by transcutaneous ultrasonography and venous occlusion plethysmography.

Authors:  H D Wu; S D Katz; A Beniaminovitz; T Khan; M R DiTullio; S Homma
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

Review 2.  Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure.

Authors:  Stuart D Katz; Haoyi Zheng
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

3.  Effects of continuous flow left ventricular assist device support on microvascular endothelial function.

Authors:  Xiaoying Lou; Danielle L Templeton; Ranjit John; Donald R Dengel
Journal:  J Cardiovasc Transl Res       Date:  2011-09-20       Impact factor: 4.132

Review 4.  Exercise and the nitric oxide vasodilator system.

Authors:  Andrew Maiorana; Gerard O'Driscoll; Roger Taylor; Daniel Green
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

5.  Understanding exercise-induced hyperemia: central and peripheral hemodynamic responses to passive limb movement in heart transplant recipients.

Authors:  Melissa A Hayman; Jose N Nativi; Josef Stehlik; John McDaniel; Anette S Fjeldstad; Stephen J Ives; D Walter Wray; Feras Bader; Edward M Gilbert; Russell S Richardson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-10       Impact factor: 4.733

Review 6.  Peripheral vascular function, oxygen delivery and utilization: the impact of oxidative stress in aging and heart failure with reduced ejection fraction.

Authors:  D Walter Wray; Markus Amann; Russell S Richardson
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

7.  Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility.

Authors:  Melissa A H Witman; Ryan S Garten; Jayson R Gifford; H Jonathan Groot; Joel D Trinity; Josef Stehlik; Jose N Nativi; Craig H Selzman; Stavros G Drakos; Russell S Richardson
Journal:  JACC Heart Fail       Date:  2015-08-12       Impact factor: 12.035

Review 8.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

9.  Reduced vascular smooth muscle BK channel current underlies heart failure-induced vasoconstriction in mice.

Authors:  Elaine Wan; Jared S Kushner; Sergey Zakharov; Xiao-Wei Nui; Neelesh Chudasama; Christopher Kelly; Marc Waase; Darshan Doshi; Guoxia Liu; Shinichi Iwata; Takayuki Shiomi; Alexander Katchman; Jeanine D'Armiento; Shunichi Homma; Steven O Marx
Journal:  FASEB J       Date:  2013-01-16       Impact factor: 5.191

Review 10.  Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction.

Authors:  Mark J Haykowsky; Corey R Tomczak; Jessica M Scott; D Ian Paterson; Dalane W Kitzman
Journal:  J Appl Physiol (1985)       Date:  2015-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.